I am a breastfeeding mother and i want to know if it is safe to use UNII-3T1SS4E7AG? Is UNII-3T1SS4E7AG safe for nursing mother and child? Does UNII-3T1SS4E7AG extracts into breast milk? Does UNII-3T1SS4E7AG has any long term or short term side effects on infants? Can UNII-3T1SS4E7AG influence milk supply or can UNII-3T1SS4E7AG decrease milk supply in lactating mothers?
No information is available on the clinical use of UNII-3T1SS4E7AG during breastfeeding. Because UNII-3T1SS4E7AG is 98.5% bound to plasma proteins and its active metabolite is 96.6% bound to plasma proteins, the amount in milk is likely to be low. However, the half-life of UNII-3T1SS4E7AG is 137 hours and it might accumulate in the infant. The manufacturer recommends that breastfeeding be discontinued during UNII-3T1SS4E7AG therapy and for at least 1 month after the end of therapy.
Disclaimer:
Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. We do not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.